Epidemiology
Etiology
Pathophysiology
Clinical features
Diagnostics
Treatment
- Lifestyle Modifications (First-line)
- Diet: 500-750 kcal/day deficit
- Exercise: ≥150 min/week moderate activity
- Target: 5-10% weight loss over 6 months
- Pharmacotherapy (BMI ≥30 or ≥27 with comorbidities)
- GLP-1 agonists: Semaglutide, Liraglutide (most effective, 10-15% loss)
- SE: Nausea, pancreatitis risk
- Orlistat: Lipase inhibitor → ↓ fat absorption
- SE: Steatorrhea, fat-soluble vitamin deficiency
- Phentermine/Topiramate: Appetite suppressant
- SE: Teratogenic (contraception required)
- Naltrexone/Bupropion
- Bariatric Surgery (BMI ≥40 or ≥35 with comorbidities)
- Roux-en-Y gastric bypass: Most effective (25-30% loss)
- SE: Dumping syndrome, vitamin deficiencies (B12, iron, folate)
- Sleeve gastrectomy: Restrictive only, lower complications
- Benefits: Resolves T2DM, HTN, OSA
- Key Comorbidities
- T2DM, HTN, OSA, NAFLD, osteoarthritis, ↑ cancer risk